Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05146_nanopub.RAJzFxUgOLhPdasGgYW2J2PjZXes54RfhZw75JYh4VOgA#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05146 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05146 label "XL820 [drugbank:DB05146]" assertion.
- drugbank:DB05146 seeAlso DB05146 assertion.
- drugbank:DB05146 identifier "drugbank:DB05146" assertion.
- drugbank:DB05146 description "XL820 is a novel small molecule anticancer compound that potently inhibits receptor tyrosine kinases (RTKs) implicated in tumor proliferation and vascularization. XL820 inhibits the VEGF receptor, KIT and the PDGF receptor, which are clinically validated targets implicated in a variety of human cancers. XL820 exhibits dose-dependent growth inhibition in models of breast carcinoma, gliomas and leukemia." assertion.
- drugbank:DB05146 title "XL820" assertion.
- drugbank:DB05146 bio2rdf_vocabulary:identifier "DB05146" assertion.
- drugbank:DB05146 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05146 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05146" assertion.
- drugbank:DB05146 bio2rdf_vocabulary:x-identifiers.org DB05146 assertion.
- drugbank:DB05146 drugbank_vocabulary:drugbank-id "DB05146" assertion.
- drugbank:DB05146 drugbank_vocabulary:x-cas cas: assertion.